BioRestorative Therapies to Participate in the 2025 Maxim Growth Summit
BioRestorative Therapies, Inc. (BRTX)
NASDAQ:AMEX Investor Relations:
biorestorative.com/content/investor-relations
Company Research
Source: GlobeNewswire
MELVILLE, N.Y., Oct. 15, 2025 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a regenerative medicine innovator focused on stem cell-based therapies and products, is pleased to announce its participation in the upcoming 2025 Maxim Growth Summit, taking place from October 22nd to 23rd at The Hard Rock Hotel NYC. Lance Alstodt, BioRestorative’s CEO, and Francisco Silva, the Company’s Vice President of Research and Development, will be participating in a panel titled “Stem Cell Therapy – A Space That is Ready to have its Day,” to be moderated by Jason McCarthy, Ph.D., Maxim Group’s Senior Managing Director, Head of Biotechnology Research. BioRestorative management will also be meeting with institutional investors in a one-on-one format during the event. Due to the format of the event, no webcast will be available. About BioRestorative Therapies, Inc. BioRestorative (www.biorestorative.com) develops therapeutic products u
Show less
Read more
Impact Snapshot
Event Time:
BRTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BRTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BRTX alerts
High impacting BioRestorative Therapies, Inc. news events
Weekly update
A roundup of the hottest topics
BRTX
News
- Biorestorative Therapies (NASDAQ:BRTX) had its "sell (e+)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- BioRestorative Granted Type B Meeting with FDA to Discuss Accelerated BLA Approval Pathway for BRTX-100 in Chronic Lumbar Disc DiseaseGlobeNewswire
- BioRestorative Therapies, Inc. (BRTX) Q3 2025 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- BioRestorative Therapies Reports Third Quarter 2025 Financial Results and Provides Business UpdateGlobeNewswire
- BioRestorative Therapies to Report Third Quarter 2025 Financial Results and Host Conference Call on November 12, 2025GlobeNewswire
BRTX
Sec Filings
- 11/18/25 - Form S-8
- 11/18/25 - Form S-1
- 11/12/25 - Form 10-Q
- BRTX's page on the SEC website